NIDAN — Nidan Laboratories and Healthcare Cashflow Statement
0.000.00%
- IN₹456.62m
- IN₹486.40m
- IN₹242.66m
- 58
- 67
- 36
- 56
Annual cashflow statement for Nidan Laboratories and Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2019 March 31st | 2020 March 31st | C2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2.23 | 7.15 | 33 | 45.2 | 48.1 |
Depreciation | |||||
Non-Cash Items | 47.5 | 37.4 | 33.6 | 19 | 19.5 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 7.36 | -30.3 | -55.1 | -12.3 | 40.3 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 89.5 | 46.2 | 43.5 | 78.3 | 139 |
Capital Expenditures | — | -0.088 | -32.2 | -70.7 | -6.68 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 9.97 | — | 0 | -287 | -23.2 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 9.97 | -0.088 | -32.2 | -357 | -29.9 |
Financing Cash Flow Items | -47.5 | -37.4 | -33.6 | -24.4 | -22.2 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -58.1 | -15.6 | -12.2 | 287 | -106 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 41.4 | 30.5 | -0.964 | 8.05 | 3.18 |